Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer

Our study aimed to explore the effect of cellular senescence and to find potential therapeutic strategies for gastric cancer. Cellular senescence-related genes were acquired from the CellAge database, while gastric cancer data were obtained from GEO and TCGA databases. SMARCA4 had the highest mutation frequency (6%), and it was linked to higher overall survival (OS) and progression-free survival (PFS). The gastric cancer data in TCGA database served as a training set to construct a prognostic risk score signature, and GEO data were used as a testing set to validate the accuracy of the signature. Patients with the low-risk score group had a longer survival time, while the high-risk score group is the opposite. Patients with low-risk scores had higher immune infiltration and active immune-related pathways. The results of drug sensitivity analysis and the TIDE algorithm showed that the low-risk score group was more susceptible to chemotherapy and immunotherapy. Most patients with mutation genes had a lower risk score than the wild type. Therefore, the risk score signature with cellular senescence-related genes can predict gastric cancer prognosis and identify gastric cancer patients who are sensitive to chemotherapy and immunotherapy.

[1]  Zhenqiang Sun,et al.  Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer , 2022, Nature Communications.

[2]  Hui Xu,et al.  Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer , 2021, EBioMedicine.

[3]  G. Melino,et al.  Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer , 2021, Cell death discovery.

[4]  Yu Lin,et al.  A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer , 2021, Disease markers.

[5]  D. Vignali,et al.  Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. , 2021, Immunity.

[6]  Xiaobo Hu,et al.  Drug metabolism‐related eight‐gene signature can predict the prognosis of gastric adenocarcinoma , 2021, Journal of clinical laboratory analysis.

[7]  Han Yang,et al.  Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer , 2021, Cancer management and research.

[8]  Hui Xu,et al.  Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma , 2021, Frontiers in Oncology.

[9]  Sheng-Xiong Zhang,et al.  Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. , 2021, Recent patents on anti-cancer drug discovery.

[10]  A. Hsu,et al.  Advances in Systemic Therapy for Gastric Cancer. , 2021, Gastrointestinal endoscopy clinics of North America.

[11]  Jide Wang,et al.  Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer , 2021, Frontiers in Genetics.

[12]  F. Bray,et al.  The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.

[13]  Stephen L. Brown,et al.  Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy , 2021, Journal of the National Cancer Institute.

[14]  S. Pervaiz,et al.  Cellular senescence: Silent operator and therapeutic target in cancer , 2021, IUBMB life.

[15]  Akiko Takahashi,et al.  Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. , 2021, Cell reports.

[16]  B. Badgwell,et al.  Current treatment and recent progress in gastric cancer , 2021, CA: a cancer journal for clinicians.

[17]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[18]  S. Senturk,et al.  The Jekyll and Hyde of Cellular Senescence in Cancer , 2021, Cells.

[19]  D. Baker,et al.  Cellular senescence in ageing: from mechanisms to therapeutic opportunities , 2020, Nature Reviews Molecular Cell Biology.

[20]  J. Gil,et al.  Senescence and the SASP: many therapeutic avenues , 2020, Genes & development.

[21]  T. Yoshikawa,et al.  Current status of immunotherapy for advanced gastric cancer. , 2020, Japanese journal of clinical oncology.

[22]  A. Azmi,et al.  Gastric cancer: a comprehensive review of current and future treatment strategies , 2020, Cancer and Metastasis Reviews.

[23]  Xiaoyuan Chen,et al.  Engineering Macrophages for Cancer Immunotherapy and Drug Delivery , 2020, Advanced materials.

[24]  Tong Zhou,et al.  Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer , 2020, Comput. Math. Methods Medicine.

[25]  J. Yewdell,et al.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion , 2020, Nature Reviews Immunology.

[26]  Annelisa M Cornel,et al.  MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy , 2020, Cancers.

[27]  Ling Wei,et al.  Noncoding RNAs in gastric cancer: implications for drug resistance , 2020, Molecular Cancer.

[28]  F. Bazzoli,et al.  Gastric cancer prevention strategies: A global perspective , 2020, Journal of gastroenterology and hepatology.

[29]  Xuan Huang,et al.  Candidate genes for predicting the survival of patients with gastric cancer: a study based on The Cancer Genome Atlas (TCGA) database , 2020, Translational cancer research.

[30]  A. Hakimi,et al.  TGF-β suppresses type 2 immunity to cancer , 2020, bioRxiv.

[31]  Zhiming Huang,et al.  The role of CXCL chemokine family in the development and progression of gastric cancer. , 2020, International journal of clinical and experimental pathology.

[32]  C. Schmitt,et al.  Cellular Senescence: Defining a Path Forward , 2019, Cell.

[33]  Tao-Tao Liu,et al.  IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1 , 2019, Digestive Diseases and Sciences.

[34]  Xiaoting Wu,et al.  FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics , 2019, Scientific Reports.

[35]  A. Butte,et al.  Widespread parainflammation in human cancer , 2016, Genome Biology.

[36]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[37]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.